WB result of MYPT1 Recombinant Rabbit mAb
Primary antibody: MYPT1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Lane 2: Caco-2 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 115 kDa
Observed MW: 140 kDa
Product Details
Product Details
Product Specification
Host | Rabbit |
Antigen | MYPT1 |
Synonyms | Protein phosphatase 1 regulatory subunit 12A; Myosin phosphatase-targeting subunit 1 (Myosin phosphatase target subunit 1); Protein phosphatase myosin-binding subunit; PPP1R12A; MBS |
Immunogen | Recombinant Protein |
Accession | O14974 |
Clone Number | S-1298-106 |
Antibody Type | Recombinant mAb |
Isotype | IgG |
Application | WB |
Reactivity | Hu, Ms |
Positive Sample | HeLa, Caco-2, NIH/3T3 |
Purification | Protein A |
Concentration | 0.5 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application | dilution | species |
WB | 1:1000 | Hu, Ms |
Background
MYPT1, or Myosin Phosphatase Targeting Subunit 1, is a regulatory subunit that binds to the catalytic subunit of protein phosphatase 1 (PP1) to form the myosin phosphatase (MP) complex. This complex is crucial for the dephosphorylation of myosin light chains, which regulates muscle contraction and relaxation. MYPT1 acts as a tumor suppressor in various cancers. It inhibits tumor progression by regulating gene expression and modulating the activity of oncogenic pathways. For instance, in prostate cancer, reduced MYPT1 expression is associated with increased tumor angiogenesis and poor patient prognosis. Similarly, in non-small cell lung cancer, MYPT1 regulated by miR-19b-3p inhibits tumor progression.
Picture
Picture
Western Blot
WB result of MYPT1 Recombinant Rabbit mAb
Primary antibody: MYPT1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: NIH/3T3 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 115 kDa
Observed MW: 140 kDa
